AMGEN Inc

NASDAQ: AMGN
$293.54
-$4.24 (-1.4%)
Closing Price on February 7, 2025

AMGN Articles

Reuters:   Apple (NASDAQ:AAPL) beat earnings forecasts. Reuters:   The IRS is probing some homebuyers’ tax credit gains. Reuters:   The US is ready to bring more insider trading cases....
These are this morning’s top day trader alert stocks with more detailed data on price, volume, and further analysis with links to each stock over at VSInvestor.com: Allion Healthcare, Inc. (NASDAQ:...
These are the top early-bird analyst upgrades and positive research calls which we have seen from Wall Street early this Monday morning: Advanced Micro Devices (NYSE: AMD) Raised to Buy at UBS. Amgen...
Updated throughout the day. Update:  Xerox (XRX) may find that IBM (IBM) or HP (HPQ) outbid it for ACS (ACS)  (Barron’s) Update:  Apple (AAPL) may be working on a touchscreen remote for an...
These are this Monday’s top day trader and active trader alert stocks in the pre-market.  We have more details on each for volume and price moves at VSInvestor.com: Delta Petroleum Corporation...
It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the overall market or even to sub-sectors within health care.  They generally trade at higher...
These are the ten top analyst upgrades,downgrades, and initiations we have seen early this Friday morning with roughly two hours until the market opens: Amgen (AMGN) Cut to Hold at Citigroup. Avery...
These are the top  10 pre-market analyst upgrades and downgrades in Wall Street research calls this Tuesday morning: Amgen (AMGN) Started as Buy at RBC. Brightpoint (CELL) Raised to Buy at...
The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis...
Reuters:   The recession has badly hurt investments in green technologies. Reuters:   Obama called for deeper China ties with the US. Reuters:   BP’s (BP) profits fell sharply. Reuters:  ...
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The...
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
These are some of the top stocks for day traders and active traders to watch based on pre-market and after-hours volume activity with links to more detailed price and volume analysis on each...
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones, the first approval...
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.